We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.
Description:
This is a preliminary phase 0 study in patients with confirmed or suspicious pancreatic cancer. Each patient will receive one dose of 68Ga-FAPI-FS by intravenous route. Dedicated whole-body PET/CT imaging will be performed. A comparative 18F-FDG PET/CT will also be performed within a week.
Sponsor:
Jagiellonian University
Contacts:
Li Huo, MDhuoli@pumch.cn
18612672038
Wenjia Zhu, MDzhuwenjia_pumc@163.com
18614080164
Government Study Link:
NCT05875753 - Click here to see study onClinicalTrials.gov